In any case, uncovering new therapeutics that aid in the timely resolution of infection is imperative to prevent bacterial dissemination that could lead to unwanted organ damage and life-threatening conditions, and GPR40 could be explored to enable this long-term objective. The gene discussed is FFAR1; the disease is infection.